Esco Technologies Inc: Form 10-Q for the period ended Mar 31, 2024
Filed with the SEC on May 10, 2024 and accepted by EDGAR at May 10, 2024, 16:25 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-01-01 to 2024-03-31 | $249.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2023-10-01 to 2024-03-31 | $467.4m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2024-01-01 to 2024-03-31 | $152.3m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2023-10-01 to 2024-03-31 | $286.5m | us-gaap:CostOfRevenue |
| Selling, general and administrative | 3 months2024-01-01 to 2024-03-31 | $55.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2023-10-01 to 2024-03-31 | $109.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 3 months2024-01-01 to 2024-03-31 | $3.2m | us-gaap:InterestExpense |
| Interest expense | 6 months2023-10-01 to 2024-03-31 | $5.9m | us-gaap:InterestExpense |
| Income tax | 3 months2024-01-01 to 2024-03-31 | $6.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2023-10-01 to 2024-03-31 | $10.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-01-01 to 2024-03-31 | $23.2m | us-gaap:NetIncomeLoss |
| Net income | 6 months2023-10-01 to 2024-03-31 | $38.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-01-01 to 2024-03-31 | $0.90 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-10-01 to 2024-03-31 | $1.49 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-01-01 to 2024-03-31 | $0.90 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-10-01 to 2024-03-31 | $1.49 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-01-01 to 2024-03-31 | 25,847,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-10-01 to 2024-03-31 | 25,846,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-10-01 to 2024-03-31 | $19.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2023-10-01 to 2024-03-31 | $16.3m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 6 months2023-10-01 to 2024-03-31 | $4.1m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months2023-10-01 to 2024-03-31 | $7.2m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-03-31 | $59.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-03-31 | $621.9m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-03-31 | $1.78bn | us-gaap:Assets |
| Current liabilities | At period end2024-03-31 | $288.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-03-31 | $617.8m | us-gaap:Liabilities |
| Long-term debt | At period end2024-03-31 | $171.0m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2024-03-31 | $20.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2024-03-31 | $1.17bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001410578-24-000723. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.